Azithromycin in Atopic Dermatitis
NCT07713186 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-07-20
Summary
The study will evaluate the role of adding azithromycin to topical treatment in patients with mild to moderate atopic dermatitis
Conditions
Interventions
- DRUG
-
Betamethasone or tacrolimus ointments
Topical treatment will be applied, Betamethasone or tacrolimus ointments
- DRUG
-
Azithromycin will be combined with topical treatment
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-01
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- Egypt
Study Locations
More Related Trials
-
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
NCT06504160 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
NCT07235384 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
NCT01174511 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
NCT03585296 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis
NCT04307862 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic Dermatitis
NCT04771910 ·Status: UNKNOWN ·Phase: NA
-
Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis
NCT00944632 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Treatments on Atopic Dermatitis
NCT01631617 ·Status: RECRUITING ·Phase: PHASE2
-
Topical Steroid Formulation and Wet Wraps
NCT02680301 ·Status: COMPLETED ·Phase: PHASE4
-
Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis
NCT00148746 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.
NCT07323719 ·Status: COMPLETED ·Phase: NA
-
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT04875169 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis
NCT02583022 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
NCT04717310 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
NCT07259343 ·Status: RECRUITING ·Phase: NA
-
Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis
NCT07205081 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
NCT01064947 ·Status: COMPLETED ·Phase: PHASE4
-
Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis
NCT04753034 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Application of AS101 for the Treatment of Atopic Dermatitis
NCT00927212 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Observation of Topical Lidocaine Cream Combined With Moisturizing Cream in the Treatment of Atopic Dermatitis
NCT07067541 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis
NCT00703573 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis
NCT02732314 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT03422822 ·Status: COMPLETED ·Phase: PHASE3